Abstract
Many studies have estimated national chronic disease costs, but state-level estimates are limited. The Centers for Disease Control and Prevention developed the Chronic Disease Cost Calculator (CDCC), which estimates state-level costs for arthritis, asthma, cancer, congestive heart failure, coronary heart disease, hypertension, stroke, other heart diseases, depression, and diabetes. Using publicly available and restricted secondary data from multiple national data sets from 2004 through 2008, disease-attributable annual per-person medical and absenteeism costs were estimated. Total state medical and absenteeism costs were derived by multiplying per person costs from regressions by the number of people in the state treated for each disease. Medical costs were estimated for all payers and separately for Medicaid, Medicare, and private insurers. Projected medical costs for all payers (2010 through 2020) were calculated using medical costs and projected state population counts. Median state-specific medical costs ranged from $410 million (asthma) to $1.8 billion (diabetes); median absenteeism costs ranged from $5 million (congestive heart failure) to $217 million (arthritis). CDCC provides methodologically rigorous chronic disease c...Continue Reading
References
Jan 30, 2003·Journal of Occupational and Environmental Medicine·Ron Z GoetzelShaohung Wang
Apr 4, 2003·Health Affairs·Joel W Cohen, Nancy A Krauss
Sep 29, 2004·Health Affairs·Kenneth E ThorpePeter Joski
Feb 6, 2008·Health Services Research·Justin G TrogdonThomas J Hoerger
Mar 1, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Jan 17, 2009·Health Services Research·Amanda A HoneycuttEric A Finkelstein
Feb 26, 2009·Health Affairs·Charles RoehrigJenny Bryant
Jan 26, 2011·Circulation·Paul A HeidenreichUNKNOWN Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research
Citations
Oct 11, 2016·Arthritis Care & Research·Kristina A TheisCharles G Helmick
Feb 13, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Grégoire de LagasnerieChristelle Gastaldi-Menager
Sep 13, 2017·Healthcare·Margaret L Campbell, Michelle Putnam
Apr 25, 2018·Journal of the American Heart Association·Jai SinghKhurram Nasir
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 5, 2016·Circulation. Cardiovascular Quality and Outcomes·Javier Valero-ElizondoKhurram Nasir
Sep 9, 2016·Journal of the American Heart Association·Javier Valero-ElizondoKhurram Nasir
Feb 2, 2018·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Oct 12, 2018·Diabetes Care·Sundar S ShresthaThomas J Hoerger
Apr 13, 2019·JAMA Network Open·Victor OkunrintemiErin D Michos
Jul 8, 2020·Physiological Reports·Jonathon W SenefeldSandra K Hunter
Aug 15, 2018·Cardiovascular Endocrinology & Metabolism·David I FeldmanKhurram Nasir
Aug 24, 2017·The New England Journal of Medicine·Adam P BressUNKNOWN SPRINT Research Group
Jan 6, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Andrew McGovernSimon de Lusignan
Nov 28, 2018·Innovation in Aging·Shinduk LeeMarcia G Ory
Mar 17, 2020·Advances in Therapy·Jesse A SussellArpamas Seetasith
Aug 23, 2020·Medical Care·Olga A KhavjouScott D Grosse
Jan 14, 2021·Journal of Global Health·Mohammad Romel BhuiaAziz Sheikh
Mar 7, 2021·Public Health Reports·Olga A KhavjouHilda Razzaghi
Apr 21, 2021·Journal of Advanced Nursing·Ana M Vargas-MartínezRocío De Diego-Cordero
May 30, 2021·Journal of Occupational and Environmental Medicine·Rowida MohamedUsha Sambamoorthi
Jul 16, 2021·Frontiers in Cardiovascular Medicine·Marta SuperviaRandal J Thomas
Aug 16, 2021·JACC. Heart Failure·Alexander ThomasNihar R Desai